Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Coiffier

Showing results (161-170 of 249) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|October 28, 2014
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter studyIsabelle Fleury, Sandy Amorim, Nicolas Mounier, et al.
Leukemia & Lymphoma|September 3, 2010
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocolPierre Morel, Jean-Nicolas Munck, Bertrand Coiffier, et al.
Haematologica|April 12, 2005
Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selectionAlexandra Traverse-Glehen, Frédéric Davi, Elsa Ben Simon, et al.
Blood|January 18, 2006
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapyNicolas Mounier, Michele Spina, Jean Gabarre, et al.
Haematologica|December 18, 2009
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 casesLucile Baseggio, Alexandra Traverse-Glehen, Florence Petinataud, et al.
Cancer|August 17, 2005
Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphomaCatherine Thieblemont, Daciana Antal, Laurence Lacotte-Thierry, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2012
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trialNicolas Mounier, Natacha Heutte, Catherine Thieblemont, et al.
Histopathology|April 25, 2013
Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 casesAlexandra Traverse-Glehen, Emmanuel Bachy, Lucile Baseggio, et al.
Leukemia & Lymphoma|June 28, 2016
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignanciesAlexandra Traverse-Glehen, Aurélie Verney, Sophie Gazzo, et al.
Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.
Pageof 25

Showing results (161-170 of 249) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|October 28, 2014
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter studyIsabelle Fleury, Sandy Amorim, Nicolas Mounier, et al.
Leukemia & Lymphoma|September 3, 2010
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocolPierre Morel, Jean-Nicolas Munck, Bertrand Coiffier, et al.
Haematologica|April 12, 2005
Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selectionAlexandra Traverse-Glehen, Frédéric Davi, Elsa Ben Simon, et al.
Blood|January 18, 2006
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapyNicolas Mounier, Michele Spina, Jean Gabarre, et al.
Haematologica|December 18, 2009
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 casesLucile Baseggio, Alexandra Traverse-Glehen, Florence Petinataud, et al.
Cancer|August 17, 2005
Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphomaCatherine Thieblemont, Daciana Antal, Laurence Lacotte-Thierry, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2012
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trialNicolas Mounier, Natacha Heutte, Catherine Thieblemont, et al.
Histopathology|April 25, 2013
Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 casesAlexandra Traverse-Glehen, Emmanuel Bachy, Lucile Baseggio, et al.
Leukemia & Lymphoma|June 28, 2016
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignanciesAlexandra Traverse-Glehen, Aurélie Verney, Sophie Gazzo, et al.
Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.
Pageof 25